BRIGHT MINDS BIOSCIENCES INC. Expense From Share-based Payment Transactions With Employees
BRIGHT MINDS BIOSCIENCES INC. (DRUG) reported Expense From Share-based Payment Transactions With Employees of CAD 880.62 thousand for the 12-month period ending 2021-09-30, per its 20-F/A filed 2022-01-18.
Discontinued
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees · last filed 2022-01-18
| Period end | Expense From Share-based Payment Transactions With Employees 4 month | Expense From Share-based Payment Transactions With Employees 12 month |
|---|---|---|
| 2021-09-30 | 880.62K CAD 20-F/A · filed 2022-01-18 | |
| 2020-09-30 | 161.30K CAD 20-F/A · filed 2022-01-18 | |
| 2019-09-30 | 0.00 CAD 20-F/A · filed 2022-01-18 |